Haryana starts clinical trials for coronavirus vaccine ‘covaxin’ at PGIMS Rohtak
Updated:5 years, 6 months ago
Updated:5 years, 6 months ago
Rohtak/ Ambala (Haryana), July 17 (ANI): Haryana started clinical trials for coronavirus vaccine ‘covaxin’ at Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences (PGIMS) in Rohtak. Vice-Chancellor OP Kalra said, “Today, we enrolled three subjects for human trails in the primary results they tolerated the vaccine very well, no adverse effect has been reported.” State Health Minister Anil Vij also commented on the trail of vaccine and said it is really good news.
Updated:5 years ago
Pan-India dry run for COVID vaccine tomorrow: Harsh Vardhan
Updated:5 years ago
PM Modi joins world leaders in condemning US Capitol siege
Updated:5 years, 1 month ago
Indo-Japan Samvad: Buddha’s message spread out from India to world, says PM Modi
Updated:5 years, 1 month ago
Centre preparing with states for past 4 months for COVID-19 vaccination: Harsh Vardhan
Updated:5 years, 1 month ago
In Jan, India may be in position to give 1st COVID vaccine shot: Harsh Vardhan
Updated:5 years, 1 month ago
Worst is over but still need to be cautious: Health Minister on COVID-19 cases in India